Baxter International Inc.
BAXHealthcareNASDAQMedical Instruments & Supplies
Scan Results
Daily timeframePart of the healthcare sector, Baxter International Inc. (BAX) is listed under Medical Instruments & Supplies. At a $9.94B market cap, Baxter International Inc. ranks as a mid-cap company within healthcare. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
Market Cap
$9.94B
Beta
0.62
P/E (TTM)
—
P/E (Fwd)
9.56
EPS (TTM)
$-1.91
EPS (Fwd)
$2.01
ROE
-15.0%
ROA
2.9%
Cash
$2.02B
Total Debt
$9.69B
Free CF
$900.9M
52W Change
-36.9%
Annual Financials
Cash vs Debt
The company holds $2.02B in cash, though total debt stands at $9.69B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Free cash flow comes in at $900.9M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -15.0% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.9% is on the lower side, which is common in asset-heavy industries. Revenue has been uneven over recent years, ranging from $10.06B to $11.24B.
The relatively low beta of 0.62 suggests BAX is a less volatile holding compared to the broader index. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Baxter International Inc. and its sector.